GPs in the UK are being encouraged to screen patients for a genetic condition that affects one in 250 women. Fragile X syndrome, described as the most common inherited cause of learning disability, remains relatively unknown to many, experts have highlighted.
The syndrome stems from an alteration to a gene on the X chromosome, disrupting the production of a vital protein necessary for brain development. It is estimated that about one in 600 men and one in 250 women carry the abnormal gene responsible for Fragile X. Female carriers of the gene also face a heightened risk of experiencing early menopause.
Individuals carrying the Fragile X pre-mutation are often unaware of their status, further underlining the importance of proactive testing. Pete Richardson, managing director of the Fragile X Society, expressed concern over the lack of awareness surrounding the condition, emphasising the need for increased screening.
Carriers are more likely to have a family history of Fragile X syndrome or other related conditions such as intellectual disability, developmental delay, or autism. Additionally, infertility issues linked to elevated follicle-stimulating hormone levels or premature ovarian failure may indicate a higher risk of being a Fragile X carrier.
A key point raised by Richardson is the need for healthcare professionals to consider Fragile X carrier status in cases of premature menopause. Timely testing and identification can lead to better support and management for individuals and families affected by the condition.
To address concerns related to Fragile X syndrome, the Fragile X Society recommends that patients who suspect they may carry the gene consult medical professionals for a Fragile X (FMR1) DNA test. This proactive approach can lead to early detection and appropriate interventions.
Sharing her personal experience, Alex McQuade highlighted the importance of genetic awareness in healthcare settings. After her sons Evan and Xander were diagnosed with Fragile X syndrome, she stressed the need for improved understanding and early detection to provide better care and support for affected individuals and families.
In conclusion, the call for GPs to conduct screenings for Fragile X syndrome underscores the significance of early detection and intervention in managing genetic conditions affecting learning and development. Increasing awareness and knowledge among healthcare professionals and the public can lead to better outcomes for individuals living with Fragile X and their families.